We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Association between evolocumab use and slow progression of aortic valve stenosis.
- Authors
Terasaka, Kengo; Gohbara, Masaomi; Abe, Takeru; Yoshii, Tomohiro; Hanajima, Yohei; Kirigaya, Jin; Horii, Mutsuo; Kikuchi, Shinnosuke; Nakahashi, Hidefumi; Matsushita, Kensuke; Minamimoto, Yugo; Okada, Kozo; Matsuzawa, Yasushi; Iwahashi, Noriaki; Kosuge, Masami; Sugano, Teruyasu; Ebina, Toshiaki; Hibi, Kiyoshi
- Abstract
No medications have been reported to inhibit the progression of aortic valve stenosis (AS). The present study aimed to investigate whether evolocumab use is related to the slow progression of AS evaluated by serial echocardiography. This was a retrospective observational study from 2017 to 2022 at Yokohama City University Medical Center. Patients aged ≥ 18 with moderate AS were included. Exclusion criteria were (1) mild AS; (2) severe AS defined by maximum aortic valve (AV) velocity ≥ 4.0 m/s; and/or (3) no data of annual follow-up echocardiography. The primary endpoint was the association between evolocumab use and annual changes in the maximum AV-velocity or peak AV-pressure gradient (PG). A total of 57 patients were enrolled: 9 patients treated with evolocumab (evolocumab group), and the other 48 patients assigned to a control group. During a median follow-up of 33 months, the cumulative incidence of AS events (a composite of all-cause death, AV intervention, or unplanned hospitalization for heart failure) was 11% in the evolocumab group and 58% in the control group (P = 0.012). Annual change of maximum AV-velocity or peak AV-PG from the baseline to the next year was 0.02 (− 0.18 to 0.22) m/s per year or 0.60 (− 4.20 to 6.44) mmHg per year in the evolocumab group, whereas it was 0.29 (0.04–0.59) m/s per year or 7.61 (1.46–16.48) mmHg per year in the control group (both P < 0.05). Evolocumab use was associated with slow progression of AS and a low incidence of AS events in patients with moderate AS.
- Subjects
AORTIC stenosis; AORTIC valve; ACADEMIC medical centers; HEART failure
- Publication
Heart & Vessels, 2024, Vol 39, Issue 8, p725
- ISSN
0910-8327
- Publication type
Article
- DOI
10.1007/s00380-024-02386-6